BG103196A - Crystalline pharmaceutical product - Google Patents

Crystalline pharmaceutical product

Info

Publication number
BG103196A
BG103196A BG103196A BG10319699A BG103196A BG 103196 A BG103196 A BG 103196A BG 103196 A BG103196 A BG 103196A BG 10319699 A BG10319699 A BG 10319699A BG 103196 A BG103196 A BG 103196A
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical product
crystalline pharmaceutical
crystalline
3oxo
bipiperidin
Prior art date
Application number
BG103196A
Other languages
Bulgarian (bg)
English (en)
Inventor
Stephen Ross
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG103196A publication Critical patent/BG103196A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG103196A 1996-09-03 1999-02-22 Crystalline pharmaceutical product BG103196A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03
PCT/US1997/015292 WO1998009629A1 (fr) 1996-09-03 1997-08-29 Produit pharmaceutique cristallin

Publications (1)

Publication Number Publication Date
BG103196A true BG103196A (en) 1999-09-30

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103196A BG103196A (en) 1996-09-03 1999-02-22 Crystalline pharmaceutical product

Country Status (32)

Country Link
US (1) US6335330B1 (fr)
EP (1) EP0964684B1 (fr)
JP (1) JP2000517342A (fr)
CN (1) CN1102391C (fr)
AP (1) AP9901472A0 (fr)
AR (1) AR008154A1 (fr)
AT (1) ATE245984T1 (fr)
AU (1) AU731173B2 (fr)
BG (1) BG103196A (fr)
BR (1) BR9711981A (fr)
CA (1) CA2264607A1 (fr)
CO (1) CO4930262A1 (fr)
CZ (1) CZ71999A3 (fr)
DE (1) DE69723873T2 (fr)
DZ (1) DZ2302A1 (fr)
EA (1) EA001363B1 (fr)
ES (1) ES2205254T3 (fr)
HU (1) HUP9904077A3 (fr)
ID (1) ID18156A (fr)
IL (1) IL128782A0 (fr)
MA (1) MA24309A1 (fr)
MY (1) MY118175A (fr)
NO (1) NO991013L (fr)
NZ (1) NZ334438A (fr)
OA (1) OA10986A (fr)
PE (1) PE107198A1 (fr)
PL (1) PL332006A1 (fr)
SK (1) SK27699A3 (fr)
TR (1) TR199900480T2 (fr)
UY (1) UY24690A1 (fr)
WO (1) WO1998009629A1 (fr)
ZA (1) ZA977870B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
KR20040058229A (ko) 2001-10-22 2004-07-03 더 스크립스 리서치 인스티튜트 항체 표적화 화합물
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
EP0593603B1 (fr) 1991-06-28 2002-11-20 Smithkline Beecham Corporation Antagonistes bicycliques de fibrinogene
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
NZ259802A (en) 1992-12-21 1997-10-24 Smithkline Beecham Corp Bicyclic derivatives and pharmaceutical compositions
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
EP0964684A4 (fr) 2002-05-29
ATE245984T1 (de) 2003-08-15
US6335330B1 (en) 2002-01-01
AR008154A1 (es) 1999-12-09
ES2205254T3 (es) 2004-05-01
EP0964684A1 (fr) 1999-12-22
SK27699A3 (en) 2000-02-14
AU4242597A (en) 1998-03-26
HUP9904077A2 (hu) 2000-05-28
NO991013D0 (no) 1999-03-02
EP0964684B1 (fr) 2003-07-30
OA10986A (en) 2003-03-04
DZ2302A1 (fr) 2002-12-28
CA2264607A1 (fr) 1998-03-12
ID18156A (id) 1998-03-05
IL128782A0 (en) 2000-01-31
DE69723873D1 (de) 2003-09-04
MA24309A1 (fr) 1998-04-01
CO4930262A1 (es) 2000-06-27
CN1234739A (zh) 1999-11-10
AP9901472A0 (en) 1999-03-31
PE107198A1 (es) 1999-03-21
JP2000517342A (ja) 2000-12-26
HUP9904077A3 (en) 2002-03-28
DE69723873T2 (de) 2004-04-22
NO991013L (no) 1999-03-02
WO1998009629A1 (fr) 1998-03-12
TR199900480T2 (xx) 1999-06-21
CN1102391C (zh) 2003-03-05
NZ334438A (en) 2000-10-27
ZA977870B (en) 1998-03-03
AU731173B2 (en) 2001-03-22
PL332006A1 (en) 1999-08-16
EA199900260A1 (ru) 1999-08-26
BR9711981A (pt) 1999-08-24
CZ71999A3 (cs) 1999-08-11
UY24690A1 (es) 1998-02-27
EA001363B1 (ru) 2001-02-26
MY118175A (en) 2004-09-30

Similar Documents

Publication Publication Date Title
HUP9602122A2 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
ZA968945B (en) 1,3-Dihydro-indol-2-one derivatives process for their preparation and the pharmaceutical compositions containing them
ZA968850B (en) Phenylacetic acid derivatives, processes and intermediate for their preparation, and compositions comprising them.
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
HUP9701264A3 (en) Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP9701265A3 (en) Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9802653A3 (en) Substituted imidazolidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9700574A3 (en) N,n-dimethyl-(3-aryl-but-3-ene)-amine derivatives, pharmaceutical compositions containing them and process for the preparation thereof
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL344219A1 (en) Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP9901473A3 (en) 2,3-benzodiazepine derivatives, process for producing them and pharmaceutical compositions containing them
AU1166895A (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-onederivatives, process for their preparation and the pharmaceutical compositions containing them
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HUP9602868A3 (en) 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9701660A3 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
HUP0004588A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them